Biblio

Author Title [ Type

] Year

Filters: Author is Davis, Kara L [Clear All Filters]

Journal Article

Long AH, Morgenstern DA, Leruste A, Bourdeaut F, Davis KL. Checkpoint Immunotherapy in Pediatrics: Here, Gone, and Back Again. Am Soc Clin Oncol Educ Book. 2022;42:1-14.

Majzner RG, Ramakrishna S, Yeom KW, Patel S, Chinnasamy H, Schultz LM, Richards RM, Jiang L, Barsan V, Mancusi R, et al. GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas. Nature. 2022.

Laetsch TW, Myers GDouglas, Baruchel A, Dietz AC, Pulsipher MA, Bittencourt H, Buechner J, de Moerloose B, Davis KL, Nemecek E, et al. Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial. Lancet Oncol. 2019.

Lin CH, Kuehn HSun, Thauland TJ, Lee CM, De Ravin SSee, Malech HL, Keyes TJ, Jager A, Davis KL, Garcia-Lloret MI, et al. Progressive B Cell Loss in Revertant X-SCID. J Clin Immunol. 2020.